Gboxin

An inhibitor of oxidative phosphorylation in cancer cells

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
5mg

￥1625.00

1300.00

- +
10mg

￥2725.00

2180.00

- +
50mg

￥10250.00

8200.00

- +
100mg

￥9700.00

7760.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

Background

Gboxin is an inhibitor of oxidative phosphorylation in cancer cells, which have a higher mitochondrial proton gradient and pH compared with non-cancerous cells.¹ It increases the mitochondrial membrane potential and reduces the oxygen consumption rate, which can be bypassed by the proton ionophore FCCP , indicating that it inhibits F₀F₁ ATP synthase/complex V. Gboxin decreases viability of three primary mouse glioblastoma cell lines (IC₅₀s = ~150 nM) and three patient-derived glioblastoma cultures (IC₅₀s = ~1 ?M) but does not affect the viability of primary mouse embryonic fibroblasts or astrocytes. It halts the cell cycle in the G₁/G₀ phase and induces apoptosis of primary low-passage glioblastoma cells pooled from multiple tumors.

1.Shi, Y., Lim, S.K., Liang, Q., et al.Gboxin is an oxidative phosphorylation inhibitor that targets glioblastomaNature567(7748)341-346(2019)